PRESS RELEASE published on 08/18/2023 at 14:50, 2 years 8 months ago Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is Ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials
PRESS RELEASE published on 08/18/2023 at 14:15, 2 years 8 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 08/18/2023 at 14:14, 2 years 8 months ago Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc
PRESS RELEASE published on 08/18/2023 at 14:00, 2 years 8 months ago Petro Welt Technologies AG: Delisting of PeWeTe shares from the Frankfurt Stock Exchange
PRESS RELEASE published on 08/18/2023 at 14:00, 2 years 8 months ago Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects
PRESS RELEASE published on 08/18/2023 at 13:50, 2 years 8 months ago EQS-Adhoc: Gerry Weber International AG: All creditor groups approve restructuring plan with large majorities
PRESS RELEASE published on 08/18/2023 at 13:30, 2 years 8 months ago EQS-Adhoc: fashionette AG publishes preliminary figures for the first half of 2023 and raises earnings forecast for 2023
PRESS RELEASE published on 08/18/2023 at 13:00, 2 years 8 months ago Open English Partners With Soccer Star Richarlison as Student and Ambassador in a R$ 2 Million Initiative That Will Donate English Courses to Underprivileged Youth in Brazil
Published on 05/09/2026 at 01:30, 2 hours 43 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 4 hours 13 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 7 hours 35 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 9 hours 1 minute ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 9 hours 11 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 8 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 9 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 9 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 1 day 10 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
